Evidence map›Paper›PMID 41284646›Full record

ArticlePLoS computational biology2025

Prediction of graft loss in living donor liver transplantation during the early postoperative period.

Raiki Yoshimura, Naotoshi Nakamura, Takeru Matsuura, Takeo Toshima, Takasuke Fukuhara, Kazuyuki Aihara, Katsuhito Fujiu, Shingo Iwami, Tomoharu Yoshizumi

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Emerging applications of traditional and generative artificial intelligence in liver transplantation.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Raiki YoshimuraInterdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
Naotoshi NakamuraInterdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
Takeru MatsuuraInterdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya, Japan.
Takeo ToshimaDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takasuke FukuharaDepartment of Virology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kazuyuki AiharaInternational Research Center for Neurointelligence, The University of Tokyo Institutes for Advanced Study, The University of Tokyo, Tokyo, Japan.
Katsuhito FujiuDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shingo IwamiInterdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Nagoya, Japan.ORCID 0000-0002-1780-350X
Tomoharu YoshizumiDepartment of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID 0000-0002-4497-1816

Funding

Institute of AI and Beyond at the University of TokyoJapan Agency for Medical Research and Development (AMED)Scientific Research (KAKENHI)
6 · The paper itself

Abstract

Liver transplantation is almost the only way to save patients with end-stage liver disease. Particularly, living donor liver transplantation (LDLT) has gained importance in recent years thanks to the shorter waiting times and better graft quality than with deceased donor liver transplantation (DDLT). However, some patients experience graft loss due to unexpected infections, sepsis, or immune-mediated rejection of the transplanted organ. An urgent need exists to clarify which patients experience graft loss. Several models have been proposed, but most analyze the classic DDLT, and knowledge about LDLT is lacking. In this study, we retrospectively analyzed clinical data from 748 patients who underwent LDLT. By adapting machine learning methods, we predicted early graft loss (within 180 days postoperatively) with better performance than conventional models. The model enabled us to stratify a highly heterogeneous sample of patients into five groups. By focusing on survival time, we next categorized the patients into three groups with early, intermediate, and late or no graft loss. Notably, we identified the intermediate-loss group as a distinct population similar to the early-loss population but with different survival times. Additionally, by proposing a hierarchical prediction method, we developed an approach to distinguish these populations using data up to 30 days postoperatively. Our findings will enable the early identification of individuals at risk of graft loss, particularly those in the early- and intermediate-loss groups. This will allow for appropriate patient care, such as switching to DDLT, identifying other living donors for LDLT, or preparing for re-transplantation, leading to a bottom-up improvement in transplant success rates.

Indexed as

Graft RejectionLiver TransplantationLiving DonorsAdultAgedComputational BiologyFemaleGraft SurvivalHumansMachine LearningMaleMiddle AgedPostoperative PeriodRetrospective Studies

Identifiers

PMID41284646
PMCPMC12671733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.